CSI Market
Sign In | Register

Mimedx Group Inc (MDXG) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MDXG Annual Cash Flow →
A period-by-period view of cash flow from Mimedx Group Inc to Jun 30 2025 helps clarify how Jun 30 2026's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-25.70
Depreciation & amortization0.78
Amortization of Other Assets0.59
Asset Retirement Obligation, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed6.75
Increase (Decrease) in Inventories-4.41
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation-0.79
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Other Share Based Compensation Expense-
Change In Fair Value Of Earn Out Liability-
Stock Issued During Period Value For Accrued Director Fees-
Stock Issued During Period Shares For Accrued Director Fees-
Stock Issued During Period Shares Cashless Exercise Of Warrants-
Impairment Of Intangible Assets-
Other Share- Based Compensation Expense-
Gain Loss On Disposition Of Property-
Impairment of Intangible Assets-
Operating Lease Rightofuse Asset Amortization-
New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification-
Operating Lease Right Of Use Asset Amortization Expense0.33
Amortization Of Intangible Assets Cost Of Sales And Operating Expenses-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-44.72
Increase (Decrease) in Accounts Payable-1.23
Increase (Decrease) in Accrued Liabilities-0.16
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Deferred Income Taxes7.70
Other Working Capital-4.91
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities54.82
Discontinued operations3.15
Net Cash flow from Operating Activities-8.14
Investing Activities
Capital Expenditures-1.17
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Held-to-maturity Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Proceeds From Reba Grant-
Payments for Application Costs Patent-
Payments For Application Costs Patent-0.07
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-5.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.11
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.28
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.02
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-12.47
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-2.03
Other net-1.36
Proceeds From Line Of Credit With Related Party-
Proceeds from Issuance of Temporary Equity-
Finance Lease Principal Payments-
Principal Payments Of Secured Debt-0.38
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-15.87
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-9.30
Total Cash Flow-30.28
4 historic quarters locked

Sign in to unlock the full Mimedx Group Inc cash flow history.

Sign In Create Free Account

About Mimedx Group Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001376339-26-000071

Figures are derived from filed reports and may be restated. Historical data is subject to revision.